Jason Aryeh Health Sciences Acquisitions Corp 2 (HSAQ) insider trading activity

HSAQ Quotes by TradingView

Jason Aryeh is Director of Health Sciences Acquisitions Corp 2. Currently has a direct ownership of 68,360 shares of HSAQ, which is worth approximately $0. The most recent transaction as insider was on Jun 20, 2024, when has been sold 5,376 shares (Common Stock, par value $0.0001 per share ("Common Stock")) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.4K
8.54% 3M change
8.54% 12M change
Total Value Held $0

Jason Aryeh Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2024
BUY
Grant, award, or other acquisition
-
5,376 Added 7.29%
68,360 Common Stock, par valu...
Apr 12 2023
BUY
Exercise of conversion of derivative security
-
11,246 Added 15.15%
62,984 Common Stock, par valu...
Jan 26 2023
BUY
Grant, award, or other acquisition
-
51,738 Added 50.0%
51,738 Common Stock, par valu...

Also insider at

LGND
LIGAND PHARMACEUTICALS INC Healthcare
Director
ANEB
Anebulo Pharmaceuticals, Inc. Healthcare
Director
JA

Jason Aryeh

Director
Emeryville, CA

Track Institutional and Insider Activities on HSAQ

Follow Health Sciences Acquisitions Corp 2 and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HSAQ shares.

Notify only if

Insider Trading

Get notified when an Health Sciences Acquisitions Corp 2 insider buys or sells HSAQ shares.

Notify only if

News

Receive news related to Health Sciences Acquisitions Corp 2

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HSAQ